Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1281895 · no price history on file
Price series unavailable — No prices available for RCKTW in [1900-01-01, 2026-07-31]. This symbol may require bring-your-own-key (BYOK) data.
| Days to cover2.9d |
Short interest is FINRA semi-monthly, settlement 2026-07-15.
RCKTW is not in the screener universe.
No return windows available for RCKTW.
No risk analytics available for RCKTW.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 36,912 | $132,145 | — | +0.0% |
| RTW INVESTMENTS, LP | 350,000 | $7,210 | — | +0.0% |
| Sio Capital Management, LLC | 400,000 | $7,020 | — | +0.0% |
| CITADEL ADVISORS LLC | 309,997 | $6,510 | — | −0.5% |
| Walleye Capital LLC | 284,345 | $5,858 | — | +0.0% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,828 | $2,159 | — | +0.0% |
| LMR Partners LLP | 75,731 | $1,560 | — | +0.0% |
| Affinity Asset Advisors, LLC | 75,000 | $1,178 | — | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. % of shares outstanding not shown: no SEC cover-page share count falls within 120 days of the 2026-Q1 quarter end, so any percentage would rest on a count that cannot speak for this quarter. Holder share counts are shown as filed.
No reported quarters on file for RCKTW.
